Lynn Kennedy

Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic NephropathyRossing P, Pedersen O, Rossing K, et al (Steno Diabetes Ctr, Gentofte, Denmark; Univ of Aarhus, Denmark) Diabetes Care 29:1024–1030, 2006§

Insulin Improves Myocardial Blood Flow in Patients With Type 2 Diabetes and Coronary Artery DiseaseLautamäki R, Airaksinen KEJ, Seppänen M, et al (Univ of Turku, Finland) Diabetes 55:511–516, 2006§

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesNathan DM, for The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (DCCT/EDIC Research Group, Bethesda, Md; Albert Einstein College of Medicine, Bronx, New York; Case Western Reserve Univ, Cleveland, Ohio; et al) N Engl J Med 353:2643–2653, 2005§

Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesNathan DM, Buse JB, Davidson MB, et al (Harvard Med School; Univ of North Carolina School of Medicine, Chapel Hill; Charles R Drew Univ, Los Angeles; et al) Diabetes Care 29:1963–1972, 2006§

Effect of Ramipril on the Incidence of DiabetesGerstein HC, and the DREAM Trial Investigators (McMaster Univ, Hamilton, Canada; et al) N Engl J Med 355:1551–1562, 2006§

Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fatO'Leary VB, Marchetti CM, Krishnan RK, et al (Case Western Reserve Univ School of Medicine, Cleveland, Ohio) J Appl Physiol 100:1584–1589, 2006§

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 DiabetesHermansen K, for the Levemir Treat-to-Target Study Group (Aarhus Univ Hosp, Denmark; et al) Diabetes Care 29:1269–1274, 2006§

Peroxisome Proliferator-Activated Receptor γ Down-Regulates Receptor for Advanced Glycation End Products and Inhibits Smooth Muscle Cell Proliferation in a Diabetic and Nondiabetic Rat Carotid Artery Injury ModelWang K, Zhou Z, Zhang M, et al (Cleveland Clinic Found, Ohio; Columbia Univ, New York) J Pharmacol Exp Ther 317:37–43, 2006§

Decreased Muscle Strength and Quality in Older Adults With Type 2 Diabetes: The Health, Aging, and Body Composition StudyPark SW, Goodpaster BH, Strotmeyer ES, et al (Pochon CHA Univ, Korea; Univ of Pittsburgh, Pa; Centers for Disease Control and Prevention, Atlanta, Ga; et al) Diabetes 55:1813–1818, 2006§

Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic β-Cell Mass and Function in a Rodent Model of Type 2 DiabetesMu J, Woods J, Zhou Y-P, et al Merck Research Labs, Rahway, NJ) Diabetes 55:1695–1704, 2006§